Zydelig® (idelalisib)
for Leukemia

Zydelig (idelalisib) is a cancer medicine used with rituximab to treat chronic lymphocytic leukemia. It interferes with the growth and spread of cancer cells and is often used after at least two prior treatments have failed or stopped working.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Leukemia